Bio-Works Technologies AB Statistics
Total Valuation
NGM:BIOWKS has a market cap or net worth of SEK 257.19 million. The enterprise value is 229.95 million.
Market Cap | 257.19M |
Enterprise Value | 229.95M |
Important Dates
The next estimated earnings date is Thursday, November 6, 2025.
Earnings Date | Nov 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
NGM:BIOWKS has 80.37 million shares outstanding. The number of shares has increased by 83.02% in one year.
Current Share Class | 80.37M |
Shares Outstanding | 80.37M |
Shares Change (YoY) | +83.02% |
Shares Change (QoQ) | +0.76% |
Owned by Insiders (%) | 25.40% |
Owned by Institutions (%) | 12.36% |
Float | 41.70M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 7.57 |
PB Ratio | 8.62 |
P/TBV Ratio | 8.62 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -6.82 |
EV / Sales | 6.77 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.37
Current Ratio | 2.37 |
Quick Ratio | 1.62 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -5,338.67 |
Financial Efficiency
Return on equity (ROE) is -122.51% and return on invested capital (ROIC) is -72.78%.
Return on Equity (ROE) | -122.51% |
Return on Assets (ROA) | -46.62% |
Return on Invested Capital (ROIC) | -72.78% |
Return on Capital Employed (ROCE) | -107.33% |
Revenue Per Employee | 1.17M |
Profits Per Employee | -1.16M |
Employee Count | 30 |
Asset Turnover | 0.79 |
Inventory Turnover | 0.81 |
Taxes
In the past 12 months, NGM:BIOWKS has paid 5,000 in taxes.
Income Tax | 5,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +150.39% in the last 52 weeks. The beta is 1.08, so NGM:BIOWKS's price volatility has been similar to the market average.
Beta (5Y) | 1.08 |
52-Week Price Change | +150.39% |
50-Day Moving Average | 2.20 |
200-Day Moving Average | 1.46 |
Relative Strength Index (RSI) | 70.25 |
Average Volume (20 Days) | 133,825 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NGM:BIOWKS had revenue of SEK 33.96 million and -33.70 million in losses. Loss per share was -0.48.
Revenue | 33.96M |
Gross Profit | 24.76M |
Operating Income | -32.03M |
Pretax Income | -33.69M |
Net Income | -33.70M |
EBITDA | -31.70M |
EBIT | -32.03M |
Loss Per Share | -0.48 |
Balance Sheet
The company has 27.24 million in cash and n/a in debt, giving a net cash position of 27.24 million or 0.34 per share.
Cash & Cash Equivalents | 27.24M |
Total Debt | n/a |
Net Cash | 27.24M |
Net Cash Per Share | 0.34 |
Equity (Book Value) | 29.84M |
Book Value Per Share | 0.38 |
Working Capital | 28.28M |
Cash Flow
Operating Cash Flow | -27.98M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 72.91%, with operating and profit margins of -94.34% and -99.24%.
Gross Margin | 72.91% |
Operating Margin | -94.34% |
Pretax Margin | -99.23% |
Profit Margin | -99.24% |
EBITDA Margin | -93.35% |
EBIT Margin | -94.34% |
FCF Margin | n/a |
Dividends & Yields
NGM:BIOWKS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -83.02% |
Shareholder Yield | n/a |
Earnings Yield | -13.10% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
NGM:BIOWKS has an Altman Z-Score of -8.27 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -8.27 |
Piotroski F-Score | 1 |